FWMNX
Price
$17.32
Change
+$0.11 (+0.64%)
Updated
Jul 9 closing price
Net Assets
142.36M
VTSAX
Price
$149.69
Change
+$0.95 (+0.64%)
Updated
Jul 9 closing price
Net Assets
1.91T
Interact to see
Advertisement

FWMNX vs VTSAX

Header iconFWMNX vs VTSAX Comparison
Open Charts FWMNX vs VTSAXBanner chart's image
Fidelity Advisor Women's Leadership I
Price$17.32
Change+$0.11 (+0.64%)
VolumeN/A
Net Assets142.36M
Vanguard Total Stock Mkt Idx Adm
Price$149.69
Change+$0.95 (+0.64%)
VolumeN/A
Net Assets1.91T
FWMNX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FWMNX vs. VTSAX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWMNX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. FWMNX (142M). VTSAX pays higher dividends than FWMNX: VTSAX (1.21) vs FWMNX (0.46). FWMNX was incepted earlier than VTSAX: FWMNX (6 years) vs VTSAX (25 years). FWMNX (0.70) is less costly to investors than VTSAX (0.04). FWMNX is a more actively managed with annual turnover of: 33.00 vs. VTSAX (2.00). FWMNX has a lower initial minimum investment than VTSAX: FWMNX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 12.27 vs. FWMNX (3.54). VTSAX return over 5 years is better than : 90.59 vs. FWMNX (59.87).
FWMNXVTSAXFWMNX / VTSAX
Total Expense Ratio0.700.041,750%
Annual Report Gross Expense Ratio0.700.041,750%
Fund Existence6 years25 years-
Gain YTD1.5375.51528%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets142M1.91T0%
Annual Yield % from dividends0.461.2138%
Returns for 1 year3.5412.2729%
Returns for 3 years40.4957.4570%
Returns for 5 years59.8790.5966%
Returns for 10 yearsN/A195.09-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTGX52.292.59
+5.21%
Protagonist Therapeutics
SONN4.640.17
+3.80%
Sonnet BioTherapeutics Holdings Inc
APP352.747.99
+2.32%
Applovin Corp
CNOB24.820.16
+0.65%
ConnectOne Bancorp
ENTA7.13-0.62
-8.00%
Enanta Pharmaceuticals